Atomic Pt-Layer-Coated Au Peroxidase Nanozymes with Enhanced Activity for Ultrasensitive Colorimetric Immunoassay of Interleukin-12
Biosensors · 09.04.2025 · 15 (4) · 239
DOI: 10.3390/bios15040239 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors, online erschienen am 09.04.2025. Verfasst von Han Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Environmental Engineering, Hubei Minzu University, Enshi 445000, China. Hauptthemen laut MEDLINE: Interleukin-12. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Shenzhen Science and Technology Innovation Commission.
Abstract (Originalsprache)
Interleukin-12 (IL-12), a crucial biomarker for immune and inflammatory responses, plays a pivotal role in diagnosing and managing diverse pathological conditions. Although colorimetric enzyme-linked immunosorbent assays (CELISAs) have been extensively employed to detect IL-12 in biological samples, their sensitivity is inherently limited by the catalytic efficiency of enzyme labels, presenting substantial challenges in achieving ultrasensitive detection and enabling pre-symptomatic diagnosis of diseases. In this study, we address this limitation by developing a novel peroxidase nanozyme, featuring ultrathin Pt skins consisting of only ~4 atomic layers, coated on Au nanoparticles (denoted as Au@Pt4LNPs). These Au@Pt4LNPs exhibit remarkable catalytic performance, achieving a ~1063-fold enhancement in peroxidase-like activity compared to horseradish peroxidase (HRP), while minimizing Pt consumption, thereby improving Pt utilization efficiency and reducing costs. This advancement facilitates the construction of an ultrasensitive CELISA capable of detecting IL-12 at femtomolar concentrations. Using Au@Pt4LNPs as the signal labels, the developed CELISA demonstrates a quantitative detection range from 0.1 to 100 pg mL−1, with a limit of detection (LOD) as low as 0.084 pg mL−1 (1.1 fM), offering ~10 times greater sensitivity than the HRP-based CELISA. This study highlights the potential of Au@Pt4LNP nanozymes as advanced signal labels, opening new avenues for next-generation ultrasensitive bioassays.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemistry and Environmental Engineering, Hubei Minzu University, Enshi 445000, China.
- Marshall Laboratory of Biomedical Engineering, Shenzhen Key Laboratory for Nano-Biosensing Technology, School of Biomedical Engineering, Shenzhen University Medical School, Shenzhen University, Shenzhen 518060, China.
ORCID-Profile: Qunfang Li, Zhuangqiang Gao
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Shenzhen Science and Technology Innovation Commission
- Shenzhen Key Laboratory for Nano-Biosensing Technology
- Research Startup Fund for Newly Recruited High-Caliber Talents in Shenzhen Higher Education Institutions
Zitieren
APA
Zhang, H., Peng, X., Song, H., Tan, Y., Xu, J., Li, Q., & Gao, Z. (2025). Atomic Pt-Layer-Coated Au Peroxidase Nanozymes with Enhanced Activity for Ultrasensitive Colorimetric Immunoassay of Interleukin-12. Biosensors, 15(4), 239. https://doi.org/10.3390/bios15040239
Vancouver
Zhang H, Peng X, Song H, Tan Y, Xu J, Li Q, et al. Atomic Pt-Layer-Coated Au Peroxidase Nanozymes with Enhanced Activity for Ultrasensitive Colorimetric Immunoassay of Interleukin-12. Biosensors. 2025;15(4):239. doi:10.3390/bios15040239
BibTeX
@article{Zhang2025,
author = {Zhang, Han and Peng, Xiang and Song, Hao and Tan, Yongfeng and Xu, Jianglian and Li, Qunfang and Gao, Zhuangqiang},
title = {Atomic Pt-Layer-Coated Au Peroxidase Nanozymes with Enhanced Activity for Ultrasensitive Colorimetric Immunoassay of Interleukin-12},
journal = {Biosensors},
year = {2025},
volume = {15},
number = {4},
pages = {239},
doi = {10.3390/bios15040239}
}
EUVIMED